Op-Eds
Are We in a Brave New World of “Personalized” Medicine?
BiDil, a new drug labeled for treatment of blacks with severe heart failure, has begun to arrive in pharmacies. Approved by FDA in…
Op-Eds
More Crop for the Drop
The worst East Central U.S. drought in almost 20 years is decimating harvests of corn and soybeans, threatening farmers’ economic survival and disrupting commercial shipping…
Op-Eds
Noisy Spring: Avoiding the West Nile virus
The six-year-old U.S. outbreak of West Nile virus is a significant threat to public health and shows no signs of abating. Last year, there were…
Op-Eds
REACH and Risk
One of the key reasons the European Union’s proposed constitution was rejected by French and Dutch voters is that they dislike having their lives…
Op-Eds
‘Big Lie’ Enough to Make Drug Industry Ill
Activism can be a good thing. We all benefit from getting to shop in the marketplace of ideas. However, all is not good-faith activism. Take,…
Op-Eds
The UN at 60, by Henry Miller and Gregory Conko
The United Nations, now celebrating the sixtieth anniversary of the signing of its charter, is not aging well. Its officials are being accused…